TX-001HR Approval Status
FDA Approved: No (Pending Approval)
Brand name: TX-001HR
Generic name: estradiol and progesterone
Company: TherapeuticsMD, Inc.
Treatment for: Perimenopausal Symptoms
TX-001HR is an investigational bio-identical hormone combination of estradiol and progesterone in development for the treatment of moderate-to-severe vasomotor symptoms due to menopause.
Development Status and FDA Approval Process for TX-001HR
|Mar 8, 2018||TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR|
|Dec 28, 2017||TherapeuticsMD Announces Submission of New Drug Application for TX-001HR|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.